3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine dihydrochloride, 97%, 250mg

Methyl 2-chloronicotinate, 98.00%, 5g

(1-oxopyrrolo[1,2-d][1,2,4]triazin-2(1H)-yl)acetonitrile, 95.0%, 1g

tert-Butyldimethyl(prop-2-ynyloxy)silane, 98%, 25g

(3R,4S,5S)-tert-butyl4-(((benzyloxy)carbonyl)amino)-3-hydroxy-5-methylheptanoate, 98%, 1g

4,4'-Di-n-nonyl-2,2'-bipyridine, 96%, 5g

4-(Trifluoromethyl)nicotinic Acid>98.0%(GC)(T)1g

2-Amino-3-methoxybenzaldehyde, 95.0%, 5g

2-(Dibutylamino)ethanol>99.0%(GC)500mL

2-Bromo-3-methoxypyridine, 97.0%, 10g

4-Methoxy-2-vinylaniline, 95.0%, 250mg

Depósito de muestras Visco, 160 ml, PTFE, FEP, 1 pieza

2-Amino-1-(4-benzyl-piperazin-1-yl)-ethanonedihydrochloride, 98.0%, 1g